Presentations
Slides and handouts are frequently made available to delegates attending medical congresses.
In an effort to provide additional value, slides are posted in our slide library, often
associated with the topic covered in a report. As a certified healthcare professional, you
may view the slides therein and download them for peer presentation or patient counselling purposes.
MEDICAL FRONTIERS - 6th International Conference on Thrombosis and Hemostasis Issues in Cancer - Bergamo, Italy / April 20-22, 2012
Treatment and Prevention of Venous Thrombosis in Cancer
MEDICAL FRONTIERS - 53rd Annual Meeting & Exposition of the American Society of Hematology - San Diego, California / December 10-13, 2011
Targeted Therapies Providing Major Clinical Advances in Myeloproliferative Neoplasms
MEDICAL FRONTIERS - 53rd Annual Meeting & Exposition of the American Society of Hematology - San Diego, California / December 10-13, 2011
Iron Chelation Associated with Improved Survival in Diverse Hematologic Disorders
PRIORITY PRESS - 53rd Annual Meeting & Exposition of the American Society of Hematology - San Diego, California / December 10-13, 2011
Simplifying Monitoring with Oral Anticoagulants
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations at the 53rd Annual Meeting & Exposition of the American Society of Hematology - San Diego, California / December 10-13, 2011
Maintenance Therapy as an Emerging Standard for Improving Survival in Multiple Myeloma
MEDICAL FRONTIERS - Canadian Association of Nephrology Nurses and Technologists (CANNT) 2011 - Calgary, Alberta / October 20-22, 2011
Partnering with Patients on Hemodialysis: Nursing Support, Advocacy and Skills
PRIORITY PRESS - XXIII Congress of the International Society on Thrombosis and Haemostasis (ISTH)/ 57th Annual Scientific and Standardization Committee (SSC) Meeting - Kyoto, Japan / July 23-28, 2011
Advances in the Treatment of Hemophilia B
MEDICAL FRONTIERS - 16th Congress of the European Hematology Association (EHA) - London, United Kingdom / June 9-12, 2011
Improving Responses to First-line Treatment in Chronic Myeloid Leukemia
